174 related articles for article (PubMed ID: 3347416)
1. Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.
Shelley WE; Starreveld AA; Carmichael JA; O'Connell G; Roy M; Swenerton K
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):327-32. PubMed ID: 3347416
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
3. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
[TBL] [Abstract][Full Text] [Related]
4. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy.
Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW
Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535
[TBL] [Abstract][Full Text] [Related]
5. Whole abdominal radiation as salvage therapy for epithelial ovarian cancer.
Hacker NF; Berek JS; Burnison CM; Heintz PM; Juillard GJ; Lagasse LD
Obstet Gynecol; 1985 Jan; 65(1):60-6. PubMed ID: 3966024
[TBL] [Abstract][Full Text] [Related]
6. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL
Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
[TBL] [Abstract][Full Text] [Related]
7. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
Chiara S; Conte PF; Bruzzone M; Falcone A; Sertoli MR; Carnino F; Mossetti C; Iura R; Durando C; Guercio E
Chemioterapia; 1987 Oct; 6(5):380-3. PubMed ID: 3427698
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
11. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer.
Dowdy SC; Metzinger DS; Gebhart JB; Srivatsa P; Haddock MG; Suman VJ; Podratz KC
Gynecol Oncol; 2005 Feb; 96(2):389-94. PubMed ID: 15661226
[TBL] [Abstract][Full Text] [Related]
12. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy after chemotherapy and second-look laparotomy in the treatment of advanced ovarian cancers].
Chauvet B; Fignon A; Lansac J; Calais G; Le Floch O
Ann Radiol (Paris); 1989; 32(2):131-5. PubMed ID: 2667432
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
16. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary.
Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP
Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second look laparotomy. A reassessment based on mature data.
Ben-Baruch G; Menczer J; Feldman B; Rizel S; Brenner H
Eur J Gynaecol Oncol; 1994; 15(4):272-6. PubMed ID: 7957334
[TBL] [Abstract][Full Text] [Related]
18. Advanced minimal residual ovarian carcinoma: abdominopelvic irradiation following combination chemotherapy.
Hainsworth JD; Malcolm A; Johnson DH; Burnett LS; Jones HW; Greco FA
Obstet Gynecol; 1983 May; 61(5):619-23. PubMed ID: 6403897
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary results.
Coeffic D; Benhammouda A; Antoine EC; Rixe O; Paraiso D; Auclerc G; Nizri D; Renody N; Grapin JP; Mularoni E; Rattini E; Soubrane C; Weil M; Mortier N; Khayat D
Semin Oncol; 1996 Dec; 23(6 Suppl 15):5-8. PubMed ID: 8996589
[TBL] [Abstract][Full Text] [Related]
20. [Abdominopelvic radiation therapy in the treatment of ovarian carcinoma. Study of a continuous series of 167 patients].
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Bull Cancer Radiother; 1994; 81(1):23-31. PubMed ID: 7893520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
